Reaction
Allodynia reporting signals
As of the last recalculation, Allodynia appears in 1,110 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is KETOPROFEN (PRR 24.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ketoprofen | 17 | 24.7 | 24.7 |
| Bupivacaine | 12 | 24.3 | 24.4 |
| Oral Semaglutide | 83 | 22.8 | 22.9 |
| Trimethoprim | 14 | 22.5 | 22.6 |
| Abiraterone | 16 | 22.3 | 22.4 |
| Tirzepatide | 154 | 20.6 | 20.6 |
| Bicalutamide | 16 | 20.0 | 20.0 |
| Tapentadol Hydrochloride | 29 | 16.7 | 16.7 |
| Phenytoin | 15 | 13.7 | 13.7 |
| Fentanyl | 61 | 12.2 | 12.2 |
| Amikacin | 10 | 11.1 | 11.1 |
| Ritonavir 100 Mg | 8 | 10.1 | 10.1 |
| Methadone | 20 | 8.9 | 8.9 |
| Fosaprepitant Dimeglumine | 6 | 8.2 | 8.2 |
| Morphine Sulfate | 50 | 8.0 | 8.1 |
| Botulinum Toxin Type A | 5 | 7.6 | 7.6 |
| Abiraterone Acetate | 16 | 7.4 | 7.4 |
| Siponimod | 3 | 6.3 | 6.3 |
| Rimegepant Sulfate | 3 | 4.4 | 4.4 |
| Galcanezumab-Gnlm | 7 | 4.2 | 4.2 |
| Minoxidil Foam 5% (Womens) | 5 | 2.9 | 2.9 |